Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome
2016 · Kidney International · 286 citations
https://doi.org/10.1016/j.kint.2015.11.026
L
Lars Pape
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
396
Papers
8.9K
Citations
48
h-index
189
i10-index
Lars Pape is an academic researcher from University of Groningen. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Organ Transplantation Techniques and Outcomes & Renal Diseases and Glomerulopathies. The author has an h-index of 48, co-authored 337 publications.
ORCID: 0000-0002-3635-6418Papers by this author
worksThe Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
2024 · Transplantation · 113 citations
https://doi.org/10.1097/tp.0000000000004976
Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
2017 · Scientific Reports · 100 citations
https://doi.org/10.1038/s41598-017-17083-w
Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study
2018 · Transplantation · 78 citations
https://doi.org/10.1097/tp.0000000000002414
The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
2021 · Orphanet Journal of Rare Diseases · 63 citations
https://doi.org/10.1186/s13023-021-01872-8
Health care transition from pediatric to adult care: an evidence-based guideline
2022 · European Journal of Pediatrics · 62 citations
https://doi.org/10.1007/s00431-022-04385-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat